Liu Wen-Jun, Li Gui-Zhen, Liu Hai-Feng, Lei Jun-Qiang
Department of Radiology, Qingyang City Hospital of Traditional Chinese Medcine, Qingyang, Gansu, China.
Department of Radiology, First Hospital of LanZhou University, Lanzhou, Gansu, China.
Echocardiography. 2018 Apr;35(4):541-550. doi: 10.1111/echo.13863. Epub 2018 Mar 23.
We sought to perform a meta-analysis to comprehensively evaluate the diagnostic accuracy of dual-source computed tomography angiography (DSCTA) in detecting coronary in-stent restenosis (CISR) when compared to invasive coronary angiography. The stent-based research studies in which DSCTA was used as diagnostic tool for CISR, as recent as of October 2017, from several reputed scientific libraries (PubMed, Embase, Scopus, The Cochrane Library, and Web of Science) were evaluated. Study inclusion, data extraction, and risk bias assessment were conducted by two researchers independently. Pooled sensitivity (SEN), specificity (SPE), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and area under summary receiver operator characteristics (SROC) curve (AUC) were calculated to assess the diagnostic value. In addition, heterogeneity and subgroup analysis were also carried out. A total of 13 studies with a total of 894 patients and 1384 assessable stents were included. The pooled results of DSCTA diagnosing CISR were as follows: SEN 0.92 (95% confidence interval [CI] 0.87-0.96), SPE 0.91 (95% CI 0.87-0.94), PLR 9.83 (95% CI 6.93-13.94), NLR 0.09 (95% CI 0.05-0.15), DOR 114.73 (95% CI 64.12-205.28), and AUC 0.97 (95% CI 0.95-0.98), respectively. The subgroup analysis result suggested that DSTCA performed significantly better in CISR detection when the stent diameter was ≥3 mm compared with the stent diameter <3 mm: (0.98 [0.97-0.99] vs 0.82 [0.79-0.86]) with P < .05. This study revealed that DSCTA has excellent diagnostic performance for detecting CISR and may serve as an alternative for further patient evaluation with CISR, especially for stent diameter ≥3 mm.
我们试图进行一项荟萃分析,以全面评估双源计算机断层扫描血管造影(DSCTA)与有创冠状动脉造影相比,在检测冠状动脉支架内再狭窄(CISR)方面的诊断准确性。对截至2017年10月,来自几个著名科学数据库(PubMed、Embase、Scopus、考克兰图书馆和科学网)中,将DSCTA用作CISR诊断工具的基于支架的研究进行评估。纳入研究、数据提取和风险偏倚评估由两名研究人员独立进行。计算合并敏感度(SEN)、特异度(SPE)、阳性似然比(PLR)、阴性似然比(NLR)、诊断比值比(DOR)以及汇总受试者工作特征(SROC)曲线下面积(AUC),以评估诊断价值。此外,还进行了异质性分析和亚组分析。共纳入13项研究,涉及894例患者和1384个可评估支架。DSCTA诊断CISR的合并结果如下:SEN为0.92(95%置信区间[CI]0.87 - 0.96),SPE为0.91(95%CI 0.87 - 0.94),PLR为9.83(95%CI 6.93 - 13.94),NLR为0.09(95%CI 0.05 - 0.15),DOR为114.73(95%CI 64.12 - 205.28),AUC为0.97(95%CI 0.95 - 0.98)。亚组分析结果表明,与支架直径<3mm相比,当支架直径≥3mm时,DSTCA在CISR检测中的表现显著更好:(0.98[0.97 - 0.99]对0.82[0.79 - 0.86]),P<0.05。本研究表明,DSCTA在检测CISR方面具有出色的诊断性能,可作为进一步评估CISR患者的替代方法,尤其是对于支架直径≥3mm的情况。